Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E Schanberg

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Lupus|May 22, 2013
Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein ID M Wahezi, N T Ilowite, X X Wu, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 16, 2020
Identifying clinically meaningful severity categories for PROMIS pediatric measures of anxiety, mobility, fatigue, and depressive symptoms in juvenile idiopathic arthritis and childhood-onset systemic lupus erythematosusC M Mann, L E Schanberg, M Wang, et al.
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|November 30, 2000
The relationship of daily mood and stressful events to symptoms in juvenile rheumatic diseaseL E Schanberg, M J Sandstrom, K Starr, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1995
Characterization of human CD7 transgenic miceL E Schanberg, D M Lee, D E Fleenor, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 14, 2024
Evaluating anchor variables and variation in meaningful score differences for PROMIS<sup>®</sup> Pediatric measures in children and adolescents living with a rheumatic diseaseC K Zigler, Z Li, A Hernandez, et al.
Lupus|August 5, 2016
Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South AfricaL B Lewandowski, L E Schanberg, N Thielman, et al.
Lupus|September 24, 2010
Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohortS P Ardoin, L E Schanberg, C Sandborg, et al.
Arthritis and Rheumatism|October 28, 2011
Use of atorvastatin in systemic lupus erythematosus in children and adolescentsL E Schanberg, C Sandborg, H X Barnhart, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Lupus|May 22, 2013
Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein ID M Wahezi, N T Ilowite, X X Wu, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 16, 2020
Identifying clinically meaningful severity categories for PROMIS pediatric measures of anxiety, mobility, fatigue, and depressive symptoms in juvenile idiopathic arthritis and childhood-onset systemic lupus erythematosusC M Mann, L E Schanberg, M Wang, et al.
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|November 30, 2000
The relationship of daily mood and stressful events to symptoms in juvenile rheumatic diseaseL E Schanberg, M J Sandstrom, K Starr, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1995
Characterization of human CD7 transgenic miceL E Schanberg, D M Lee, D E Fleenor, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 14, 2024
Evaluating anchor variables and variation in meaningful score differences for PROMIS<sup>®</sup> Pediatric measures in children and adolescents living with a rheumatic diseaseC K Zigler, Z Li, A Hernandez, et al.
Lupus|August 5, 2016
Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South AfricaL B Lewandowski, L E Schanberg, N Thielman, et al.
Lupus|September 24, 2010
Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohortS P Ardoin, L E Schanberg, C Sandborg, et al.
Arthritis and Rheumatism|October 28, 2011
Use of atorvastatin in systemic lupus erythematosus in children and adolescentsL E Schanberg, C Sandborg, H X Barnhart, et al.
Pageof 2